Prazosin GITS vs Atenolol in Patients with Hypertension and Normal Lipid Profile : A Randomized, Controlled Multicenter Study

Journal of Association of Physicians of India

Volumn SUPPL. 1, Issue , 1998, Pages 41-51

  Joglekar, S J ^a   Jaguste, Veena ^a   Nanivadekar, A S ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; LIPID; PRAZOSIN;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; FEMALE; HEART; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ATENOLOL; DELAYED-ACTION PREPARATIONS; FEMALE; HEART; HUMANS; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED; PRAZOSIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 2542607812     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Stanaszek WF, Kellerman D, Brogden RN, Romankiewicz JA. Prazosin update : A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure. Drugs 1983; 25:339-84.
2. Johnson BF and Danylchuk MA. The relevance of plasma lipid changes with cardiovascular drug therapy. Med Clin N Am 1989; 73 (2) : 449-73.
3. Barbieri C, Ferrari C, Borzio M, Piepoli V, Caldara R. Metabolic effects of chronic prazosin treatment. Horm Metab Res 1980; 12:331-4.
4. Rouffy J and Jaillard J. Effects of two antihypertensive agents on lipids, lipoproteins, and apoproteins A and B. Am J Med 1986; 80 (S2A) : 100-3.
5. Kaplan NM. Primary Hypertension : Natural history, special populations, and evaluation. In : Clinical Hypertension, 6th Ed., Baltimore, Maryland : Williams & Wilkins, 1994; 127.
6. Gosse P and Dallocchio M. Prazosin LP versus acebutolol dans le traitement de l'hypertension arterielle essentielle moderee. Etude comparative. Tempo Medical 1991; 445/ 446 (Suppl) : 2-3.
7. Joglekar SJ and Nanivadekar AS. Prevalence of lipid and glycaemic abnormalities in hypertensive patients : A retrospective survey. Ind Heart J 1996; 48:371-4.
8. Joglekar SJ, Kularni SS, Nanivadekar AS. Prevalence of dyslipidaemia in hypertensive patients. A retrospective survey. Ind Practitioner 1996; XLIX (5): 405-10.